Form 4 for IRMD IRADIMED CORP
Accepted 2025-04-04 00:00:00 ET · period of report 2024-06-20 · accession 0001415889-25-010210 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-04 | 2024-06-20 | IRMD | GLENN JOHN | CFO | M - OptEx | — | +5,796 | 10.2K | +132% | — |
| D | 2025-04-04 | 2024-06-20 | IRMD | GLENN JOHN | CFO | F - Tax | $42.53 | -1,412 | 8,767 | -14% | -$60.1K |
| D | 2025-04-04 | 2024-06-20 | IRMD | GLENN JOHN | CFO | M - OptEx | $0.00 | +5,796 | 11.6K | +100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-20 | M | A | 5,796 | — | 10,179 | D | — | — | (F1) Represents shares of common stock that the Reporting Peron received upon the vesting of restricted stock units ("RSUs") on a one-for-one basis. (F2) The transaction was inadvertently reported late. The aggregate amount of securities beneficially owned includes the delinquent transaction plus all transactions reported in Form 4's filed after the date of the delinquent transaction. |
| 2 | Common | Common Stock | 2024-06-20 | F | D | 1,412 | $42.53 | 8,767 | D | — | — | (F2) The transaction was inadvertently reported late. The aggregate amount of securities beneficially owned includes the delinquent transaction plus all transactions reported in Form 4's filed after the date of the delinquent transaction. |
| 3 | Derivative | Restricted Stock Units | 2024-06-20 | M | A | 5,796 | $0.00 | 11,592 | D | — · 2024-06-20 to — | 5,796 Common Stock | (F1) Represents shares of common stock that the Reporting Peron received upon the vesting of restricted stock units ("RSUs") on a one-for-one basis. (F3) The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. |